My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eli Lilly (NY:LLY)

1,076.98 +5.34 (+0.50%)

Official Closing Price Updated: 5:00 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

99 100 Next >

Stay informed with the top movers within the S&P500 index on Thursday. ↗

August 07, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Eli Lilly (NYSE:LLY) Reports Bullish Q2 But Stock Drops 14.4%

August 07, 2025

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 37.6% year on year to $15.56 billion. The company’s full-year revenue...

Via StockStory

Elanco (NYSE:ELAN) Delivers Impressive Q2, Stock Jumps 15.4%

August 07, 2025

Animal health company Elanco (NYSE:ELAN) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.8% year on year to $1.24 billion. Guidance for next quarter’s revenue was...

Via StockStory

Intel, Eli Lilly, Fortinet, Duolingo, Nebius: Stocks Making The Biggest Moves Today ↗

August 07, 2025

Via Stocktwits

Eli Lilly’s Oral Obesity Drug Leads To Over 12% Weight Loss In Late-stage Study ↗

August 07, 2025

Via Stocktwits

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Why Eli Lilly Stock Is Plunging Today ↗

August 07, 2025

Lilly's late-stage results for its experimental oral obesity drug raised concerns.

Via The Motley Fool

Eli Lilly Co. Q2 FY2025 Earnings Transcript ↗

August 07, 2025

Eli Lilly delivered a strong Q2 2025 with 38% revenue growth and major clinical milestones, despite a selloff over obesity drug trial data.

Via Benzinga

Why Are Eli Lilly’s Shares Crashing Today Despite Strong Earnings? ↗

August 07, 2025

Eli Lilly's stock crashed over 14% despite strong Q2 earnings, as disappointing weight-loss pill trial results overshadowed 38% revenue growth and raised guidance.

Via Talk Markets

Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations

August 07, 2025

Indianapolis, IN – Shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) experienced a significant downturn, plummeting over 10% in premarket trading and continuing to slide throughout the...

Via MarketMinute

Topics Economy

Apple Jumps, Eli Lilly Crashes On Worst Day In 25 Years: What's Moving Markets Thursday? ↗

August 07, 2025

U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove divergent moves in heavyweight names.

Via Benzinga

Topics Government World Trade

Exploring the top movers within the S&P500 index during today's session. ↗

August 07, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Upcoming Earnings Calls This Week: August 4th - August 10th, 2025

August 07, 2025

This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial...

Via MarketMinute

Topics Artificial Intelligence Economy

Intel Stock Falls After Trump Says CEO 'Must Resign' ↗

August 07, 2025

Intel stock fell after President Trump said CEO Lip-Bu Tan "must resign," saying he is "highly conflicted."

Via Investor's Business Daily

Topics Government Law Enforcement

Thursday's session: gap up and gap down stock in the S&P500 index ↗

August 07, 2025

Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors ↗

August 07, 2025

Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure, and Terns amid promising trial updates.

Via Benzinga

Eli Lilly (LLY) Q2 Revenue Jumps 38% ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

Lilly Shares Tumble As Weak Weight-Loss Pill Data Overshadows Strong Earnings ↗

August 07, 2025

Eli Lilly shares plunged in premarket trading after disappointing results from its new weight-loss drug overshadowed strong second-quarter results and raised full-year guidance.

Via Talk Markets

Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge. ↗

August 07, 2025

An analyst called the unexpected flop a "once-in-a-blue-moon" occasion for Eli Lilly's dominant weight-loss franchise.

Via Investor's Business Daily

Eli Lilly's Closely Watched Obesity Pill Orforglipron Shows Around 12% Weight Loss But Trails Novo Nordisk ↗

August 07, 2025

Eli Lilly shares fell after orforglipron's Phase 3 data showed less weight loss than rival drugs, despite a strong Q2 earnings beat and raised guidance.

Via Benzinga

Topics Earnings

These S&P500 stocks are moving in today's pre-market session ↗

August 07, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?

Via Chartmill

Eli Lilly & Co (NYSE:LLY) Reports Strong Q2 2025 Earnings Beat but Faces Pre-Market Decline Amid Market Skepticism ↗

August 07, 2025

Eli Lilly (LLY) beat Q2 2025 earnings with strong Mounjaro & Zepbound demand, but shares fell 13% pre-market amid profit-taking and high expectations. Raised guidance signals confidence.

Via Chartmill

Topics Earnings

Peloton Reportedly Laying Off 6% Of Its Staff In Another Round Of Job Cuts To Trim Expenses ↗

August 07, 2025

According to a CNBC report, the company plans to reduce run-rate expenses by another $100 million in fiscal year 2026, on top of the $200 million it cut in fiscal 2025, half of which will come from...

Via Stocktwits

Topics Workforce

Dow Futures Rise As Trump’s Reciprocal Tariff Deadline Kicks In: AAPL, NVDA, INTC, LLY, SRPT Among Stocks To Watch ↗

August 07, 2025

Via Stocktwits

Topics Government Stocks

Stock Market Today: US Futures Rise Amid Russia Peace Talk Update—Investors Await Eli Lilly, Block Earnings ↗

August 07, 2025

U.S. stock futures rose on Thursday after ending higher on Wednesday. Futures of major benchmark indices were up.

Via Benzinga

Nvidia Stake, Vision Funds Boost Softbank’s Q1 Results As Masayoshi Son’s Investment Company Looks To Ramp Up AI Bets ↗

August 07, 2025

Softbank recorded an investment gain of 559.7 billion yen, helped by gains from its stake in Nvidia and strong performances by its SoftBank Vision Funds.

Via Stocktwits

Topics Artificial Intelligence Government

Nasdaq, S&P 500 Futures Climb Despite Trump Tariff Rollout — Spotlight On Jobs Data, Eli Lilly, Warner Bros. Earnings ↗

August 07, 2025

Via Stocktwits

Topics Government Stocks

Nasdaq Surges Over 1% Amid Jump In Apple Shares: Fear & Greed Index Remains In 'Neutral' Zone ↗

August 07, 2025

Via Benzinga

Eli Lilly, ConocoPhillips And 3 Stocks To Watch Heading Into Thursday ↗

August 07, 2025

Via Benzinga

Why Novo Nordisk Stock Slipped Today ↗

August 06, 2025

The Danish pharmaceutical company is fighting a competitive war on several fronts.

Via The Motley Fool

Topics Lawsuit

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.